From miw@fw5.sacserv.com Thu May 5 22:21:52 2005 [2005-05-05 22:21:52 125811]
Received: from mail.sacserv.com (mail.sacserv.com [216.70.30.232])
by www.munged.ext (8.11.6/8.11.6) with SMTP id j462Lqa00468
for <chien@munged.ext>; Thu, 5 May 2005 22:21:52 -0400
Received: (qmail 31040 invoked from network); 5 May 2005 02:19:32 -0000
Received: from unknown (HELO mail6.sacserv.com) (127.0.0.1)
by 0 with SMTP; 5 May 2005 02:19:32 -0000
Message-ID: <5421336.1115259572414.JavaMail.miw@localhost>
Date: Wed, 4 May 2005 21:19:32 -0500 (CDT)
From: E-mailNewsService <biomednews@aol.com>
Reply-To: E-mailNewsService <biomednews@aol.com>
To: chien@munged.ext
Subject: BMN PRESS RELEASE: No. of Principal Investigators in US is
Declining, Says Tufts Ctr for Study of Drug Development
X-Sub-ID: 3412705
X-Camp-ID: 141594
BMN PRESS RELEASE
Contact: Peg Hewitt
Tufts Center for the Study of Drug Development
617-636-2185 phone
peg.hewitt@tufts.edu
NUMBER OF PRINCIPAL INVESTIGATORS IN THE US IS DECLINING, ACCORDING TO TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT
-- Continuation of the trend could "pose several threats" to drug companies
http://sacserv.com/links.jsp?linkid781&subid412705&campid1594&type=0
BOSTON MA USA -- MEDICAL INDUSTRY E-MAIL NEWS SERVICE(TM) -- MAY 04 2005 -- Following steady growth through the 1990s, the number of principal investigators conducting industry-sponsored clinical studies in the US has declined 11% since 2001, claims a new study recently completed by the Tufts Center for the Study of Drug Development.
The drop in principal investigators has been spurred by a similar decline in the number of active clinical trials, the study found.
According to Tufts CSDD, a 10.6% decline in clinical trials has led to an 11.4% drop in total principal investigators in the US between 2001 and 2003.
The study, the first of its kind to assess the principal investigator landscape, also found that turnover rates among principal investigators in the US have nearly doubled since 2001. In comparison, regional and gender disparities among principal investigators have grown.
Tufts CSDD conducted extensive analyses of a database of over 100,000 principal investigators who registered with the US Food & Drug Administration to conduct clinical trials of investigational drugs between 1977 and 2004.
CAPACITY TO CONDUCT CLINICAL TRIALS IS ERODING:
"The decline in the number of principal investigators and the high turnover rate pose several threats to research sponsors," noted Ken Getz, research fellow at Tufts CSDD and author of the study.
"The capacity of the market to conduct clinical trials for industry sponsors is eroding. Efforts to establish a well-trained, experienced pool of clinical investigators may become more difficult."
Growing gender & regional disparities:
In addition, he said, growing gender and regional disparities among principal investigators will limit professional opportunities, and potentially diminish scientific and economic benefits to declining regions. "This, in turn, could make it more difficult to recruit representative patient populations," said Getz.
Commenting on the significance of the study's findings, Tufts CSDD Director Kenneth I Kaitin said, "As the time, cost and risk of new product development increases, pharmaceutical and biotech companies are looking to identify bottlenecks and improve efficiency of every facet of drug development. We believe this study will help them assess and improve their management of investigative sites."
FINDINGS:
The Tufts Center's analysis, summarized in the just-published May/June Tufts CSDD Impact Report, also found that:
-- While the total number of principal investigators in the US decreased from 2001 to 2003, their counterparts outside the US increased by 8%.
-- By 2000, half of all principal investigators in the US chose never to conduct another clinical trial - nearly double the turnover rate observed 10 years before.
-- The proportion of female-to-male principal investigators in the US is steadily declining, and is significantly below the overall ratio of female-to-male board certified physicians.
-- Only 3% of all board certified physicians are principal investigators, and a growing percentage of principal investigators are migrating to the South region of the US
TUFTS CSDD IMPACT REPORTS:
For more information on the Tufts CSDD Impact Reports - a bimonthly publication presenting original analyses and insights on a host of mission-critical issues relating to the nature and pace of drug development, visit:
ABOUT THE TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT:
The Tufts Center for the Study of Drug Development at Tufts University provides strategic information to help drug developers, regulators and policy makers improve the quality and efficiency of pharmaceutical development, review and utilization.
The Tufts Center, based in Boston, conducts a wide range of in-depth analyses on pharmaceutical issues. The Tufts Center hosts symposia, workshops and public forums on related topics. It also publishes the Tufts CSDD Impact Report, a bimonthly newsletter providing analysis and insight into critical drug development issues.
FOR FURTHER INFORMATION, PLEASE EMAIL TUFTS CSDD AT:
csdd@tufts.edu
Peg Hewitt
Tufts Center for the Study of Drug Development
Tufts University
192 South St Ste 550
Boston MA USA 02111
617-636-2185 phone
617-636-2425 fax
peg.hewitt@tufts.edu
http://sacserv.com/links.jsp?linkid785&subid412705&campid1594&type=0
Please forward this press release to colleagues who may want to read it.
-----------
EDITOR'S NOTE: The opinions, claims/statements in this press release are solely those of the author. The Medical Industry E-mail News Service(TM) & BMN Inc accept no legal liability/responsibility for its contents/transmission.
According to legal experts & federal requirements, this press release FULLY complies w/the CAN-SPAM Act, each of its provisions, & all applicable/current state/federal laws & regulations. This electronic newsletter & daily news transmittal service are Constitutionally-protected publications. Like the wire services, these are PAID transmittals of a news announcement & newsletter -- not an advertisement -- via the "Medical Industry E-Mail News Service(TM)." It's the world's 1st/largest, press release/newsletter distribution service focused exclusively on the medical product mfg industry.
ADD ME: If you/colleagues want to be added to this comp press release distribution list, please click below, or email: biomednews@aol.com
http://sacserv.com/links.jsp?linkid786&subid412705&campid1594&type=0
READERSHIP: Pass-around e-mail forwarding generates a total readership of approx. 300,000-500,000 persons in almost 200 countries. Includes: valuable middle to top mgmt, key execs, decision-makers & regulatory affairs professionals at almost every US medical product mfgr/supplier & medical service provider. Over 800 leading medical trade associations, major universities, medical ctrs/hospitals, medical publishers, medical product mfg/service providers, law firms, regulatory organizations, US Federal Govt, & economic devel organizations, often use our E-mail News Service(TM).
TO ORDER: To place an order to transmit your press release to over 200,000 individual e-mail addresses of medical industry execs worldwide, please contact BMN Inc: jemailnews@aol.com or click below to charge your 1st order:
http://sacserv.com/links.jsp?linkid787&subid412705&campid1594&type=0
2770 S Harbor Bl Ste H
Santa Ana CA USA 92704-5835
714-549-4180 phone
jemailnews@aol.com
http://sacserv.com/links.jsp?linkid788&subid412705&campid1594&type=0
-----------
Delete/Add/Change Requests: We honor all delete requests. To be removed from this distribution list, or to change/add your email #, please follow the simple instructions below. Or, forward the entire press release to: biomednews@aol.com & type: "Please Delete" in the subjectline. That way we can use computer coding at the tail end to correctly match it to your exact email #. Please allow 1-3 business days to take effect. Not asking to be deleted means that you consent to receive press releases & confirms there is an ongoing business correspondent relationship.
To be removed from future e-mail transmittals, please click on the following link or copy and paste it into your web browser and press the RETURN key.
http://sacserv.com/unsubscribe.jsp?subid412705&custidv&campid1594
link redirects to:
http://csdd.tufts.edu/InfoServices/Order.pdf
For more information, call 617-636-2170, email julie.medway@tufts.edu, or visit http://csdd.tufts.edu
http://csdd.tufts.edu/InfoServices/Contact.asp
Mailing Address:
Tufts Center for the Study of Drug Development
Tufts University
192 South Street, Suite 550
Boston, MA 02111
USA
order link redirects to:
http://www.biomedical-market-news.com/cgi-local/SoftCart.exe/online-store/scstore/p-000000000158.html?E+scstore
Biomedical Market Newsletter
NEWSLETTERS
COMPANY DIRECTORIES
FDA REGULATORY MANUALS
MARKET RESEARCH STUDIES
MAIL LISTS & DATABASES
3237 Idaho Pl - Costa Mesa CA USA 92626-2207
(800) 875-8181 toll free phone
(714) 434-9500 phone
(714) 43409755 fax
http://www.biomedical-market-news.com
http://www.biomedical-market-news.com/cgi-local/SoftCart.exe/online-store/scstore/sitepages/about.html?L+scstore+tmsf5734ff072a07+1117519122
EDITORIAL & CIRCULATION OFFICE:
Biomedical Market Newsletter, Inc.
3237 Idaho Place
Costa Mesa, CA USA 92626-2207
(714) 434-9500 phone
(714) 434-9755 fax
biomednews@aol.com
info@biomedical-market-news.com
SALES OFFICE:
Biomedical Market Newsletter, Inc.
2770 S Harbor Blvd, Ste H
Santa Ana, CA USA 92704-5835
714-549-4180 phone
714-549-4266 fax
Dave Anast Publisher/Editor/CEO (714) 434-9500 phone info@biomedical-market-news.com
Steve Baker Director of Marketing & Sales (714) 435-1824 phone steve@biomedical-market-news.com
John Stone Director of E-mail News Service Sales (714) 549-4180 phone john@biomedical-market-news.com
Richard Guiss Senior Editor (714) 549-4180 phone richard@biomedical-market-news.com
Athey Anast Business Manager (714) 434-9500 phone
George Anast CFO (714) 434-9500 phone
Biomedical Market Newsletter
3237 Idaho Place
Costa Mesa, CA USA 92626-2207
(714) 434-9500 phone
(714) 434-9755 fax
(800) 875-8181 toll free phone (US only)
info@biomedical-market-news.com
Registrant:
Tufts University
169 Holland Street
Somerville, MA 02144
UNITED STATES
Contacts:
Administrative Contact:
Tufts Network Operations
Tufts University
169 Holland Street
Somerville, MA 02144
UNITED STATES
(617) 627-2550
noc@net.tufts.edu
Technical Contact:
Same as above
Name Servers:
NS1.TUFTS.EDU 130.64.1.8
NS2.TUFTS.EDU 130.64.5.8
NS1.HIGHWIRE.ORG
NS2.HIGHWIRE.ORG
Domain record activated: 22-Jun-1987
Domain record last updated: 28-Jun-2002
tufts.edu has address 130.64.1.83
www.tufts.edu is an alias for lb.www.tufts.edu.
lb.www.tufts.edu has address 130.64.1.83
csdd.tufts.edu has address 155.212.10.127
[whois.networksolutions.com]
Registrant:
MIW LLC (SBFWZIBUHD)
223 West Michigan Street
Duluth, MN 55802
US
Domain Name: SACSERV.COM
Administrative Contact, Technical Contact:
MIW LLC (25884456O) domains@duluthmn.com
223 West Michigan Street
Duluth, MN 55802
US
218-722-5000 fax: 218-733-0130
Record expires on 19-May-2005.
Record created on 19-Dec-2003.
Database last updated on 9-May-2005 20:01:54 EDT.
Domain servers in listed order:
DNS1.MM-INTERACTIVE.COM 216.70.31.3
DNS2.MM-INTERACTIVE.COM 216.70.25.3
sacserv.com has address 216.70.30.233
www.sacserv.com has address 216.70.30.233
[whois.networksolutions.com]
Registrant:
Biomedical Market Newsletter
3237 Idaho Place
Costa Mesa, CA 92626
US
Domain Name: BIOMEDICAL-MARKET-NEWS.COM
Administrative Contact:
Isaacs, David disaacs@mdwtech.com
MDW Technologies, LLC
20101 S.W. Birch St.
Suite 130-D
NEWPORT BEACH, CA 92660-1748
US
949-757-0341 fax: 949-757-0456
Technical Contact:
Heuer, Marco mh3_nsi@MHE.COTSE.NET
Biomedical Market Newsletter
3237 Idaho Place
Costa Mesa, CA 92626
US
(714) 434-9500 fax: (714) 662-1167
Record expires on 10-May-2012.
Record created on 09-May-1995.
Database last updated on 9-May-2005 19:59:49 EDT.
Domain servers in listed order:
NS19A.NAMESERVERS.NET 161.58.134.98
NS19B.NAMESERVERS.NET 161.58.134.114
biomedical-market-news.com has address 161.58.146.150
www.biomedical-market-news.com has address 161.58.146.150
